- Home
- PTHL vs CEE Comparison
PTHL vs CEE Comparison
Compare PTHL & CEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTHL
- CEE
- Stock Information
- Founded
- PTHL 1998
- CEE 1990
- Country
- PTHL China
- CEE Germany
- Employees
- PTHL N/A
- CEE N/A
- Industry
- PTHL
- CEE Finance Companies
- Sector
- PTHL
- CEE Finance
- Exchange
- PTHL Nasdaq
- CEE Nasdaq
- Market Cap
- PTHL 60.5M
- CEE 79.2M
- IPO Year
- PTHL 2024
- CEE N/A
- Fundamental
- Price
- PTHL $4.17
- CEE $11.22
- Analyst Decision
- PTHL
- CEE
- Analyst Count
- PTHL 0
- CEE 0
- Target Price
- PTHL N/A
- CEE N/A
- AVG Volume (30 Days)
- PTHL 44.1K
- CEE 22.0K
- Earning Date
- PTHL 02-11-2025
- CEE 01-01-0001
- Dividend Yield
- PTHL N/A
- CEE 3.86%
- EPS Growth
- PTHL N/A
- CEE N/A
- EPS
- PTHL N/A
- CEE N/A
- Revenue
- PTHL $572,291.00
- CEE N/A
- Revenue This Year
- PTHL N/A
- CEE N/A
- Revenue Next Year
- PTHL N/A
- CEE N/A
- P/E Ratio
- PTHL N/A
- CEE N/A
- Revenue Growth
- PTHL 2.32
- CEE N/A
- 52 Week Low
- PTHL $3.32
- CEE $7.80
- 52 Week High
- PTHL $6.45
- CEE $10.32
- Technical
- Relative Strength Index (RSI)
- PTHL N/A
- CEE 43.27
- Support Level
- PTHL N/A
- CEE $10.92
- Resistance Level
- PTHL N/A
- CEE $11.75
- Average True Range (ATR)
- PTHL 0.00
- CEE 0.41
- MACD
- PTHL 0.00
- CEE -0.09
- Stochastic Oscillator
- PTHL 0.00
- CEE 22.39
About PTHL Pheton Holdings Ltd Class A Ordinary Shares
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.
About CEE The Central and Eastern Europe Fund Inc. (The)
CENTRAL & EASTERN EUROPE FUND, INC. is a closed-end management investment company. The Fund's objective is to seek long-term capital appreciation. It invests in the equity or equity-linked securities of issuers domiciled in Central and Eastern Europe.